Suspension of trading
Acorda Therapeutics Stock OTC Markets
Stocks
ACOR
US00484M7002
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0135 USD | -3.57% |
|
-10.00% | -99.91% |
| 24-08-13 | First Motion for Exclusivity Period Extension Approved For Acorda Therapeutics, Inc. | CI |
| 24-08-07 | Modified First Amended Joint Liquidation Plan Approved for Acorda Therapeutics, Inc. | CI |
| 1 week | -10.00% | ||
| 1 month | -87.85% | ||
| 3 months | -98.41% | ||
| 6 months | -99.90% | ||
| Current year | -99.91% |
| 1 week | 0.01 |  | 0.02 |
| 1 month | 0.01 | | 0.15 |
| 3 years | 0.01 | | 99.8 |
| 5 years | 0.01 | | 535.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sofia Ali
COO | Chief Operating Officer | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.57% | -10.00% | -99.92% | -99.98% | 16.77K | |
| +1.03% | +2.30% | +54.92% | +111.78% | 55.58B | |
| +2.72% | +3.26% | +47.26% | +47.26% | 43.47B | |
| +1.12% | +2.79% | -13.71% | -17.53% | 22.64B | |
| +1.17% | +3.85% | +1.00% | +401.79% | 20.96B | |
| +3.81% | -5.07% | +12.00% | -29.52% | 15.79B | |
| +0.15% | +2.24% | +9.10% | -40.04% | 15.3B | |
| -0.69% | +0.82% | +27.17% | +178.31% | 13.45B | |
| +5.27% | +5.54% | +14.25% | - | 11.74B | |
| +1.61% | +1.28% | +92.88% | +215.31% | 10.96B | |
| Average | +1.80% | +0.97% | +14.50% | +85.27% | 23.32B | |
| Weighted average by Cap. | +1.71% | +1.61% | +31.91% | +100.79% |
Employees
-
- Stock Market
- Stocks
- ACOR.Q Stock
- ACOR Stock
Select your edition
All financial news and data tailored to specific country editions
